Chemical Business Newsbase articles from November 2009

Chemical Business Newsbase archives from November 2009

Small Talk: Asian Plantations to bring palm oil to Aim.
November 30, 2009... Palm oil, which is predominantly produced in Malaysia and Indonesia, is used in a whole range of foods, such as bread, biscuits and breakfast cereal. In order to harvest the stuff, vast tracts of rainforest are being chopped down, further...

Small Talk: Indian Energy set for boost from extra wind-power tariff.
November 30, 2009... Indian Energy, the India-focused renewable-energy group, is likely to get a boost when the Indian Government announces the introduction of the 'Generation Based Incentive' scheme for independent power producers in wind-power projects, which is...

Kangaroos may hold skin cancer cure: study.
November 30, 2009... Kangaroos may provide the key to a potential treatment to prevent skin cancer, Australian scientists said on Mon 30 Nov 2009. Researchers at Melbourne University are investigating whether a DNA repair enzyme found in the jumping marsupials could...

Oral dosage form new animal drugs; chlortetracycline powder.
November 30, 2009... The US Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Alpharma Inc, 440 Route 22, Bridgewater, NJ, USA. ANADA 200-441 provides for the...

Importer of controlled substances; notice of application (Aptuit).
November 30, 2009... Aptuit, 10245 Hickman Mills Drive, Kansas City, MO, USA, made application to the US Drug Enforcement Administration (DEA) on 30 Sep 2009 for registration as an importer of poppy straw concentrate, a basic class of controlled substance listed in...

Importer of controlled substances; notice of registration (Clinical Supplies Management Inc).
November 30, 2009... Clinical Supplies Management Inc, 342 42nd Street, South Fargo, ND, USA, made application by renewal to the US Drug Enforcement Administration (DEA) on 8 Sep 2009 to be registered as an importer of sufentanil, a basic class of controlled...

In the matter of certain R-134a coolant (otherwise known as 1,1,1,2-Tetrafluoroethane) enforcement proceeding; notice of commission determination not to review an enforcement initial determination finding no violation of a consent order; termination of th.
November 30, 2009... Notice is hereby given that the US International Trade Commission has determined not to review the enforcement initial determination (EID) issued by the presiding administrative law judge (ALJ)on 21 Sep 2009 in the matter of certain R-134a...

Titan Energy, Suniva set up unit in Bengal.
November 30, 2009... The US-based Suniva Inc, manufacturer of monocrystalline silicon solar cells has completed setting up a 1 MW solar electric power plant in collaboration with Titan Energy Systems at Jamuria in West Bengal. The capacity of the plant is set to be...

Government to impose trans fat limits on vanaspati soon: Manufacturers say move will force them to fully depend on imports.
November 30, 2009... The Government of India plans to impose limit on the content of trans fatty acids in Vanaspati to 10% by early 2010 and further to 5% by 2012. Trans fatty acids are liked to coronary hear diseases and diabetes. The Food Safety & Standards...

Planet Biopharmaceuticals (PBPH) announces annual meeting and results of clinical trials.
November 30, 2009... Planet Biopharmaceuticals Inc and its wholly owned subsidiaries, a speciality pharmaceutical company focused on providing products for allergy and asthma sufferers, announced the results of initial phase II clinical trials for its sublingual...

Lorus Therapeutics Inc (LRP) raises $2.46 M in equity financing.
November 30, 2009... Lorus Therapeutics Inc (Lorus) announced that it has completed an equity financing in the amount of $2.46 M by way of a private placement of 41 M units (the Units), each Unit consisting of one common share of Lorus and one-half common share...

ALDA Pharmaceuticals Corp enters into agreement with Shoppers Drug Mart.
November 30, 2009... ALDA Pharmaceuticals Corp has entered into an agreement with Shoppers Drug Mart Corp ('Shoppers') that will make the company's T36 Antiseptic Hand Sanitizer available in over 1170 Shoppers Drug Mart and Pharmaprix stores across Canada. ALDA...

Ambrilia Biopharma Inc and ZBx Corp extend the exclusive licence option agreement for the worldwide rights to Ambrilia's PSP94 technology for prostate cancer diagnosis.
November 30, 2009... Ambrilia Biopharma Inc has extended the exclusive licence option agreement with ZBx Corp that granted ZBx the worldwide rights to develop, manufacture and commercialize Ambrilia's PSP94 technology in ZBx's Zap Rapid Test System and Assays. The...

Cytokinetics Inc to present non-clinical data relating to CK-2017357 at the 5th Cachexia Conference.
November 30, 2009... Cytokinetics Inc announced that a poster and oral presentation summarizing non-clinical data regarding CK-2017357, a fast skeletal troponin activator, are scheduled to be presented at the 5th Cachexia Conference, organized by the Society on...

GENFIT Corp: A new potential indication for Gft505, diabetes associated fatty liver diseases.
November 30, 2009... GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic diseases, revealed complementary beneficial effects of its most advanced...

Eurand launches ZENPEP (Pancrelipase) delayed-release capsules.
November 30, 2009... Eurand NV, a global speciality pharmaceutical company, announced the commercial availability of ZENPEP (pancrelipase) Delayed-Release Capsules, a pancreatic enzyme product (PEP) indicated for the treatment of exocrine pancreatic insufficiency...

Lorus Therapeutics Inc announces positive result in its Phase II clinical study of LOR-2040 in acute myeloid leukemia (AML).
November 30, 2009... Lorus Therapeutics Inc, a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced that its Phase II clinical trial in refractory and relapsed AML...

Theravance Inc receives complete response letter on the telavancin NDA for the treatment of nosocomial pneumonia.
November 30, 2009... Theravance Inc announced that it received a Complete Response letter from the US Food and Drug Administration (FDA) related to the telavancin New Drug Application (NDA) for the treatment of nosocomial pneumonia (NP). Telavancin is a...

Theravance Inc announces that European Medicines Evaluation Agency has completed the validation phase for the telavancin MAA for the treatment of nosocomial pneumonia and complicated skin and soft tissue infections.
November 30, 2009... Theravance Inc announced that the European Medicines Agency (EMEA) has completed the validation phase for the Marketing Authorization Application for telavancin, a bactericidal, once-daily injectable lipoglycopeptide antibiotic, for the...

ReNeuron awarded two grants under regenerative medicine funding.
November 30, 2009... ReNeuron Group plc has been awarded two grants under the Government-backed Technology Strategy Board's Regenerative Medicine Programme. This funding programme was launched earlier during 2009 to underpin and enable the best regenerative medicine...

Suven Life Sciences Ltd secures three European patents on NCEs.
November 30, 2009... Suven Life Sciences Ltd (Suven) announces that the European Patent Office (EPO) has issued 3 new Patents: EP1537113, EP1704154 and EP1856132 corresponding to three New Chemical Entities (NCEs) for the treatment of disorders associated with...

Neovacs SA's preliminary clinical trial results (Presented at the GASTRO conference) are supportive of the safety, immunogenicity and therapeutic effect of the company's kinoid approach; clinical testing is to be expanded.
November 30, 2009... Neovacs, a biotechnology company developing proprietary immunotherapeutics for autoimmune and chronic diseases, released a summary of the presentation made in London, UK. The presentation featured preliminary data from the ongoing Phase I/II...

SIBUR shareholders decide to increase the charter capital to continue funding of the investment programme.
November 30, 2009... At the absentee meeting of shareholders of SIBUR Holding JSC it was decided to issue additional common shares in the total amount up to Roubles 9 bn for shareholders. SIBUR Holding JSC intends to issue up to 3,469,545 additional common shares....

Cannasat Therapeutics Inc reports results for the nine months ended 30 Sep 2009.
November 30, 2009... Cannasat Therapeutics Inc (Cannasat) announced its results for 3Q and nine months ended 30 Sep 2009 and operational highlights for 3Q 2009. The company reported cash and cash equivalents at 30 Sep 2009 of C$ 811,080. For 3Q 2009, the company's...

BioSyent Inc releases 2009 3Q financial results.
November 30, 2009... BioSyent Inc released a summary of its 3Q and nine months ended Sep 2009 financial results. During 3Q 2009 sales increased by 17% from $431,841 in 3Q 2008 to $540,870 in 3Q 2009. Total Sales fell by 5% from $956,414 in nine months of 2008 to...

ReNeuron: Interim results for the six months ended 30 Sep 2009.
November 30, 2009... ReNeuron announced its financial highlights and operational highlights for the 1H ended 30 Sep 2009. Loss for 1H 2009-2010 was GBP 1.9 M (-39% from GBP 3.1 M). Net cash outflow from operating activities reduced by 50% to GBP 1.5 M in 1H 2009...

Vectura Group plc: Interim results for 1H ended 30 Sep 2009.
November 30, 2009... Vectura Group plc (Vectura) announces its interim results for 1H ended 30 Sep 2009. Vectura posted revenues of GBP 22.8 M in 1H 2009-2010 (+71% over GBP 13.3 M in 1H 2008-2009). Gross profit was GBP 21.2 M in 1H 2009-2010 (+86% over GBP 11.4 M...

State determined the list of medicines with fixed price.
November 30, 2009... The Russian government has highlighted 658 drugs that are considered vitally important from the 2617 drugs currently registered in the country. 67.2% of these 658 drugs are produced by domestic companies or by a joint venture based in Russia...

Greenland needs third partner for aluminium project.
November 30, 2009... A third partner will probably be needed for an aluminium works in Greenland involving the government and Alcoa Inc. The government has the right to acquire a 50% stake in the project but is neither willing nor has the financial scope. Alcoa...

S Africa: electricity prices halt aluminium projects.
November 30, 2009... There will be no new aluminium projects in S Africa in the near future because a rise in electricity prices is inevitable. Rio Tinto only recently postponed a works in Coega partly because of difficulties with electricity supply.

Morocco: $4 bn for the phosphate industry.
November 30, 2009... Moroccan phosphate producer Office Cherifien des Phosphates (OCP) is planning to invest around $4 bn on expanding the port of Jorf Lasfar. An expansion of the Khourigba and Gantour mines is also on the agenda. A 140 km transport pipeline to the...

Phoenix Solar enters the US solar market.
November 30, 2009... Phoenix Solar is considering entering the US market. The company's supervisory board has approved a proposal for set up a subsidiary based in California that will probably commence its activities in 1H 2010. Considerable potential for growth is...

Hungary: Hankook investing EUR 230 M in tyre plant.
November 30, 2009... Korean tyre maker Hankook is expanding its plant in Racalmas, Hungary. In the next two years additional investment of EUR 230 M at the site will take the overall figure to EUR 550 M. The plant currently producer 15,000 tyres/day. Capacity is to...

BASF commissions new intermediates plant.
November 30, 2009... BASF commissioned a new complex for the production of cyclopentanone (Cpon) and cyclodecanone (Cdon) in Ludwigshafen on 30 Nov 2009. Total capacity is 30,000 tonnes/y and over EUR 100 M was invested. Nitrous oxide will be used as oxidizing agent...

ChemGenex to present positive data for Omapro from multiple clinical trials at ASH.
November 30, 2009... ChemGenex Pharmaceuticals Ltd announced that updated clinical data from several of its clinical trials with Omapro (omacetaxine mepesuccinate) will be presented at the upcoming 51st American Society of Hematology (ASH) Annual Meeting in New...

PanGenex signs licensing deal to enter the $600 M Spirulla market.
November 30, 2009... PanGenex Corp (PanGenex) announced that it has solidified plans to expand its retail product line with the addition of spirulla. Spirulla, a blue green algae, is an abundant and sustainable natural source of protein, essential fatty acids,...

Synovis Life Technologies announces publication of Veritas article in The American Journal of Surgery.
November 30, 2009... Synovis Life Technologies Inc announced that The American Journal of Surgery has published an article on the performance of Synovis' Veritas Collagen Matrix for the repair of complex ventral hernias. Veritas is an extremely conformable and...

Human Genome Sciences announces proposed public offering of common stock.
November 30, 2009... Human Genome Sciences Inc announced that it has commenced an underwritten public offering of up to 12,500,000 shares of its common stock. The company intends to grant the underwriters a 30-day option to purchase up to an additional 1,875,000...

First commercial order for Changda International's Thiophene from French drug giant.
November 30, 2009... Changda Intl Holdings has received a first commercial order for it product Thiophene from Sanofi Aventis, the French pharmaceutical multinational. The order was preceded by a rigid due diligence process undertaken by Sanofi on Changda Intl and...

Wedgewood Pharmacy introduces tiny tabs for Megestrol Acetate, Famciclovir.
November 30, 2009... In response to requests from veterinarians, Wedgewood Pharmacy is now compounding Tiny Tabs in Megestrol Acetate 5 mg and Famciclovir 31.25 mg. Megestrol Acetate is commonly prescribed by veterinarians for behavioural- and dermatological-related...

Titan receives Notice of Allowance for Probuphine patent application in the treatment of opiate addiction.
November 30, 2009... Titan Pharmaceuticals Inc announced that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's US patent application directed to the use of Probuphine for the treatment of opiate addiction. The patent...

PPD completes acquisition of BioDuro.
November 30, 2009... PPD Inc has completed its acquisition of BioDuro LLC, a drug discovery outsourcing company focused on integrated drug discovery programmes and services. With this acquisition, PPD now employs more than 1400 in Asia Pacific and nearly 1000 people...

Terapio secures $5 M in Series A financing from Sante Ventures.
November 30, 2009... Terapio Corp has secured $5 M in equity financing from Sante Ventures. Terapio is developing a pipeline of therapeutic applications based on the unique properties RLIP76, a transport protein that helps move large molecules across the cell...

Inovio Partner announces completion of phase I DNA vaccine study.
November 30, 2009... Inovio Biomedical Corp announced that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio's electroporation technology. The study established the safety...

Depomed files patent infringement lawsuit against Lupin Limited.
November 30, 2009... Depomed Inc announced that it has filed a lawsuit in the US District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceuticals Inc, for infringement of the patents listed in the...

Emisphere Technologies announces extension of maturity date for Novartis convertible promissory note.
November 30, 2009... Emisphere Technologies Inc (Emisphere) announced that Novartis Pharma AG (Novartis) has agreed to extend the maturity date of Emisphere's Convertible Promissory Note to 26 Feb 2010. The $10 M original principal amount Note, plus interest accrued...

MagForce Nanotechnologies AG applies for European regulatory approval of its Nano-Cancer therapy.
November 30, 2009... MagForce Nanotechnologies AG has submitted the product file for NanoTherm to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now...

Allos Therapeutics announces issuance of US patent for FOLOTYN.
November 30, 2009... Allos Therapeutics Inc announced that the US Patent and Trademark Office has issued a patent for the use of FOLOTYN (pralatrexate injection) for the treatment of T-cell lymphoma. US Patent No 7,622,470 was issued to Memorial-Sloan Kettering...

Xencor licenses Antibody Optimisation Technology.
November 30, 2009... Xencor, Inc a company using Fc engineering for the discovery and development of next-generation and biosuperior antibodies, announced that it has licensed its XmAb and Xtend technology platforms to Centocor Research & Development, Inc for...

Emergent Health Corp reports further progress.
November 30, 2009... Emergent Health Corp Emergent is pleased to report about 90% revenue growth for the first nine months of 2009 is $160,101.90 ($83,400.40 in first nine months of 2008). Projected earnings/share for nine months of 2009 before income taxes are...

ReSearch Pharmaceutical Services, Inc (RPS) establishes global platform to capitalize on outsourced clinical trials.
November 30, 2009... ReSearch Pharmaceutical Services Inc a next generation contract research organization (CRO) and provider of integrated clinical development outsourcing solutions, announced the completion of its global platform to provide advanced integrated CRO...

NanoViricides files Quarterly Report.
November 30, 2009... NanoViricides, Inc reports that the company has filed its quarterly report with the SEC on 23 Nov. The company reported that it had $4.2 M in cash and cash equivalents as of 30 Sep 2009. The company previously reported that it had successfully...

Three Lou Gehrig's Disease (ALS) Organizations grant funding for research collaboration between RXi Pharmaceuticals and UMass Medical School.
November 30, 2009... Three prominent philanthropic organizations - The Angel Fund, The ALS Therapy Alliance and Project ALS -- dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world's...

Covidien completes sale of oxygen therapy product line.
November 30, 2009... Covidien announced that it had completed the previously announced sale of its Oxygen Therapy assets to Chart Industries Inc. The sale of the Oxygen Therapy product line, which includes products sold under the Companion and Helios brands, was...

Spectrum Pharmaceuticals announces completion of enrolment in one apaziquone Phase III pivotal trial for bladder cancer ahead of schedule.
November 30, 2009... Spectrum Pharmaceuticals announced that one of the two Phase III pivotal clinical trials of apaziquone has achieved its enrolment target, having enrolled approximately 800 patients with non-invasive bladder cancer. The second Phase III clinical...

Calgon Carbon announces entry into Memorandum of Understanding.
November 30, 2009... Calgon Carbon Corp announced that it has entered into a nonbinding Memorandum of Understanding with Mitsubishi Chemical Corp regarding the buyout of Mitsubishi Chemical Corp's 51% equity interest in Calgon Mitsubishi Chemical Corp. Calgon...

Evolution Fuels provides recap of stock dividends.
November 30, 2009... Evolution Fuels Inc provided an update and a recap of the recently announced dividends of common stock the company holds in certain publicly traded companies. The record date for the previously announced dividend of Southwest Resources Inc has...

Chiyoda announced award of basic design and engineering package contract for Pulau Bukom Refinery in Singapore.
November 30, 2009... Chiyoda Singapore (Pte) Limited, signed a Contract with Shell Eastern Petroleum Limited in Singapore for Basic Design and Engineering Package (BDEP) for its Pulau Bukom Refinery for a desulphurisation facilities on 7 Oct 2009. The work will be...

Evolution Fuels releases corporate profile on Evolution Resources pursuant to recent dividend and stock split.
November 30, 2009... Evolution Fuels Inc releases a corporate profile on Evolution Resources pursuant to the recently announced stock split and dividend, whereby 2 M shares of EVLN stock will be disbursed to current shareholders of Evolution Fuels in the form of a...

Affinity Gold Corp announces financing.
November 30, 2009... Affinity Gold Corp announced that it has obtained financing of $500,000 through two separate loan agreements to the company. The company plans to use the proceeds to acquire the appropriate equipment necessary for setting up operations to...

Inbicon, Otoka, and Great River Energy sign MOU, plan biomass refinery in US.
November 30, 2009... Inbicon A/S announced the signing of a multi-party Memo of Understanding to pursue the licensing, development, and construction of a biomass refinery in North Dakota. Inbicon's new collaborators are Otoka Energy, a US developer of renewable...

Far East Energy announces continued increase in gas production and possible pipeline sales in summer of 2010.
November 30, 2009... Far East Energy Corp (Far East) announced that gas production from its Shouyang Block in Shanxi Province, China, continues to increase steadily and has achieved another milestone, now surpassing 400,000 cu ft/day. The rate of increase in...

China Gengsheng Minerals renews full-service refractory contract and regenerative bricks contract with Shandong Iron and Steel Group, Rizhao subsidiary.
November 30, 2009... China Gengsheng Minerals Inc (China Gengsheng) announced that it has renewed a full-service refractory contract and regenerative bricks contract with Shandong Iron and Steel Group (Shandong), Rizhao subsidiary. The combined total value of the...

Oil Refineries' notifies on new decree relating to emissions from the refinery.
November 30, 2009... Oil Refineries Ltd announced that it has come to its knowledge that Israel's Minister for the Environmental Protection signed on 22 Nov 2009, new instructions for the prevention of air pollution from the Haifa refinery, under the Prevention of...

Albemarle to increase price of Saytex CP-2000 brominated flame retardant.
November 30, 2009... Albemarle Corp will increase the price of Saytex CP-2000 brominated flame retardant by $0.30/kg on all shipments from 1 Jan 2010 or as contracts allow. Albemarle Corp, headquartered in Baton Rouge, LA, is a leading global developer, manufacturer...

Mosaic announces segment realignment and phosphate asset write-offs.
November 30, 2009... The Mosaic Company announced that it has realigned its business segments to more clearly reflect the company's evolving business model. The realignment includes moving from three to two business segments by combining the Offshore business...

Li3 Energy Inc announces a letter of intent to acquire Puna Lithium Corp.
November 30, 2009... Li3 Energy Inc is pleased to announce it has signed a letter of intent to acquire Puna Lithium Corp (Puna). Puna has an option to acquire up to an aggregate 80% interest in 123,000 acres of prime Chilean salar ground located across 9 Chilean...

Air Products signs long-term hydrogen contract for Shell's new unit at its Pernis refinery.
November 30, 2009... Air Products, the leading global hydrogen provider, announced it has signed a long-term agreement to supply hydrogen to Shell for one of the new units at its refinery complex near Rotterdam, the Netherlands. Air Products will supply Shell the...

KEMET introduces two new high temperature ceramic dielectric platforms which include first-to-market Ultra Stable X8R.
November 30, 2009... KEMET Corp announced the launch of two new high temperature dielectric platforms -- Ultra Stable X8R and X8L dielectrics. Ultra Stable X8R and X8L Dielectric SMD MLCCs feature a 150 degrees C maximum operating temperature, offering the latest in...

CPV REC announces Maryland's largest solar farm in conjunction with ACPT planned green community.
November 30, 2009... CPV Renewable Energy Company announced plans for a 10 MW solar farm in southern Maryland to be co-located with the proposed natural gas combined-cycle CPV St Charles Energy Center. The announcement was made as part of American Community...

Endicott Biofuels and TransAlgae collaborate to develop renewable fuels from algae oil.
November 30, 2009... Endicott Biofuels LLC, a Houston-based, next-generation biodiesel producer, and TransAlgae Ltd, an algal biotechnology company, have signed a Memorandum of Understanding for the development of algae as a potential transportation fuel and...

Governor Rendell: Major solar project in Philadelphia Navy Yard to create 400 jobs.
November 30, 2009... Governor Edward G. Rendell announced that one of the world's most competitive and innovative thin-film solar panel producers will open a manufacturing facility in Philadelphia's Navy Yard, creating 400 jobs and leveraging hundreds of millions of...

EnerSys acquires Oerlikon battery business.
November 30, 2009... EnerSys, the world's largest manufacturer, marketer, and distributor of industrial batteries, announced that it has completed the acquisition of the industrial battery businesses of the Swiss company Accu Holding AG. Enersys acquired the stock...

Cenergy Power Commissions Solar System for Enaqua.
November 30, 2009... Enaqua, a leading water purification solutions provider, installed a 50.4kW Direct Current solar power system for its new expansion facility in San Diego. They chose Cenergy Power, a leading commercial solar integrator, to engineer and construct...

Tronox Announces TiO2 Price Increase.
November 30, 2009... Tronox Incorporated, on behalf of its subsidiary companies, announced the following price increase for all titanium dioxide grades effective 1 Dec 2009 or as contracts allow: Asia Pacific $150/tonne. This increase is in addition to those...

Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban Silver Antimicrobial Technology.
November 30, 2009... Microban International Ltd, the global leader in built-in antimicrobial product protection, is pleased to announce their exclusive North America partnership with Dal-Tile Corp, the largest US manufacturer and distributor of ceramic tile and...

OmniActive and Kemin Reach amicable settlement in patent dispute.
November 30, 2009... Kemin Foods, LC and OmniActive Health Technologies, Inc and OmniActive Health Technologies, Ltd have reached an amicable settlement of their dispute. The parties agree that Kemin's US Patent No 5,382,714 titled 'Process for Isolation,...

Cytokine PharmaSciences completes Phase I study of oral anti-inflammatory agent, CPSI-23.
November 30, 2009... Cytokine PharmaSciences Inc (Cytokine) has announced the completion of a Phase I study of CPSI-2364, its orally active, small-molecule inhibitor of the production of TNF-alpha and other pro-inflammatory cytokines. Results of the safety and...

QRxPharma initiates pivotal Phase III study of MoxDuo IR for moderate to severe acute pain.
November 30, 2009... QRxPharma Ltd announced that as part of its Phase III programme, the initiation of a registration trial (Study 008) comparing efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of...

EMD Serono receives refuse to file letter from FDA on Cladribine tablets New Drug Application.
November 30, 2009... EMD Serono Inc announced that it received a refuse to file letter from the US Food and Drug Administration (FDA) on the New Drug Application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine,...

Bayer HealthCare Pharmaceuticals initiates Phase III Trial with florbetaben PET Tracer for imaging of cerebral beta-amyloid plaques, a pathological hallmark of Alzheimer's disease.
November 30, 2009... At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Bayer HealthCare Pharmaceuticals Inc (Bayer) announced the enrolment of the first patient in an international Phase III clinical trial to evaluate...

FDA grants orphan drug designation for 3,4-DAP for LEMS.
November 30, 2009... BioMarin Pharmaceutical Inc (BioMarin) announced that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic...

Hard to Treat Diseases closes $1 M contract with Indian pharmaceutical.
November 30, 2009... Hard to Treat Diseases' operating subsidiary Mellow Hope finalized contract details with one of the largest manufacturer of intravenous medication in India. This contract promises additional increase in revenues for Hard to Treat Diseases in...

Sanofi-aventis US and Intelliject Inc sign licensing agreement for novel epinephrine auto injector in North America.
November 30, 2009... Sanofi-aventis US announced the signing of an exclusive licensing agreement with Intelliject Inc for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (US and Canada)....